|
About Plasma
Plasma Safety
The immunoglobulin used in replacement therapy is made from
human plasma. Plasma is the liquid portion of blood,
which also contains red and white blood cells and platelets.
Just like people can donate blood, they can also donate plasma.
People who take immunoglobulin therapy usually take it for
their whole life. Because of this, the safety of their immunoglobulin
is extremely important. To ensure the highest safety margins,
Baxter has developed a state-of-the-art quality assurance process.
It starts with a rigorous screening
and donation process.
|
Plasma is obtained from donors
demonstrating a commitment to ongoing participation.
To accomplish this, the initial donation
from each Donor Applicant is quarantined until the donor
returns for at least a second donation (usually within
2 months) and again demonstrates negative test results
in serological testing. |
Pooling of plasma from donors
who have passed all the above steps
All plasma donations from
qualified donors are tested for various viral markers. |
Placement of each qualified
donor’s plasma on a 60-day inventory hold
This allows time to see if qualified
donors have developed any infections
since they first donated plasma, and, if so, their plasma
will be discarded and not used in final processing. The
first donation from every donor is discarded unless he or
she becomes a qualified repeat donor. |
It continues with a state-of-the-art, multi-step
manufacturing process to obtain high quality products.
|
